Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Yasminelle completes European mutual recognition procedure

May 11, 2006

Quigley begins clinical testing of QR-333 in diabetic peripheral neuropathy

May 11, 2006

Bionovo advancing MF-101 for vasomotor symptoms

May 11, 2006

New patents cover novel antidiabetic agents

May 9, 2006

Enjuvia now available in U.S.

May 9, 2006

NDA submission for Gestiva for prevention of preterm birth

May 9, 2006

Positive phase III findings for Evamist

May 9, 2006

Nonproprietary name lorcaserin hydrochloride approved for APD-356

May 9, 2006

Manhattan to study oleoyl-estrone for obesity in phase IIa study

May 9, 2006

Prous Science online journals add multimedia component

May 9, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...